Meridian Medical Secures $72.9M Defense Contract for Nerve Agent Auto-Injectors

Meridian Medical Technologies LLC, St. Louis, Missouri, has been awarded a maximum $72,940,000 firm-fixed-price, indefinite-delivery/indefinite-quantity contract for antidote treatment nerve agent auto-injector. This was a sole-source acquisition using justification 10 U.S. Code 3204 (c)(1), as stated in the Federal Acquisition Regulation 6.302-1. This is a one-year base contract with two one-year option periods. The ordering period end date is Dec. 7, 2026. Using customers are Army, Navy, Air Force, Marine Corps, and Coast Guard. Type of appropriation is fiscal 2026 through 2027 defense working capital funds. The contracting activity is Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-26-D-0001).